ClinicalTrials.Veeva

Menu
North America Research Institute | NARI Lynwood, CA logo

North America Research Institute | NARI Lynwood, CA

Research site

Site insights

Top conditions

Top treatments

Tenapanor
MK-2060
Retatrutide
Phosphate

Parent organization

This site is a part of North America Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Molly Way

Verified by this site

Active trials

3 of 4 total trials

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

The purpose of this study is to evaluate the efficacy and safety of two different doses of MK-2060 (a monoclonal antibody against Factor XI) in end s...

Active, not recruiting
End-Stage Renal Disease
End-Stage Kidney Disease
Drug: MK-2060
Drug: Placebo

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Enrolling
Overweight and Obesity
Drug: Retatrutide
Drug: Placebo
Locations recently updated

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Trial sponsors

Ardelyx logo
Lilly logo
Merck Sharp & Dohme (MSD) logo
Novo Nordisk logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems